Crescent Park Management’s Elanco Animal Health ELAN Stock Holding History

Crescent Park Management’s Portfolio ELAN Stock Details ELAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-162,950	Closed	-$4.63M	–	41
2021 Q4	$4.63M	Sell	162,950 -795,986	-83%	-$24.8M	0.75%	26
2021 Q3	$30.6M	Buy	958,936 +77,500	+9%	+$2.6M	4.49%	8
2021 Q2	$30.6M	Buy	881,436 +74,006	+9%	+$2.44M	4.53%	10
2021 Q1	$23.8M	Sell	807,430 -24,922	-3%	-$766K	4.02%	11
2020 Q4	$25.5M	Sell	832,352 -293,780	-26%	-$8.96M	3.73%	10
2020 Q3	$31.5M	Sell	1,126,132 -467,280	-29%	-$11.8M	5.28%	7
2020 Q2	$34.2M	Sell	1,593,412 -275,170	-15%	-$6.08M	7.05%	4
2020 Q1	$41.8M	Buy	1,868,582 +682,082	+57%	+$18.7M	10.19%	2
2019 Q4	$34.9M	Buy	1,186,500 +290,000	+32%	+$7.88M	6.28%	7
2019 Q3	$23.8M	Buy	+896,500	New	+$26.9M	4.92%	11

Other funds holding ELAN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

SHCM

Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Crescent Park Management's ELAN Position: Q1 2022 in Review

Crescent Park Management sold out of Elanco Animal Health (ELAN) in Q1 2022, closing a stake of 162,950 shares — an estimated $4.63M sold.

Crescent Park Management first reported a position in ELAN in Q3 2019 and held it in 10 quarters. The position peaked at $41.8M in Q1 2020. 472 funds tracked by Wall St. Rank hold ELAN as of Q1 2022.

Crescent Park Management reported no remaining Elanco Animal Health position as of Q1 2022 after selling out during the quarter.
Crescent Park Management sold 162,950 Elanco Animal Health shares in Q1 2022, an estimated $4.63M.
Crescent Park Management first reported a position in Elanco Animal Health in Q3 2019 and held it in 10 quarters.
Crescent Park Management's Elanco Animal Health position peaked at $41.8M in Q1 2020.
472 funds tracked by Wall St. Rank held Elanco Animal Health as of Q1 2022.

Based on Crescent Park Management's 13F filing for Q1 2022, filed 13 May 2022.